Veeva Systems Inc. Class A Common Stock (VEEV)
Stock · NYSE · Technology
$310.92as of 10/16/2026
Price chart
Active signals
VEEV Signal Track Record
How signals performed across all stocks →What VEEV's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakout | 34 | -0.2% | 47% | October 9, 2026 |
| Volume Spike | 29 | +3.7% | 59% | September 18, 2026 |
| 200-Day Moving Average TouchActive now | 19 | -0.6% | 47% | July 31, 2026 |
| Bollinger Band Breakdown | 16 | +3.0% | 63% | April 8, 2026 |
| Any 20-session window (baseline) | +1.4% | 57% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About VEEV
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end co…
- Sector
- Technology
- Industry
- Computer Software: Prepackaged Software
- Employees
- 7,928
- Website
- www.veeva.com/medtech/
Fundamentals
- 1-day range
- $296.56$313.47
- Market cap
- $35.54B
- P/E (trailing)
- 47.36
- P/E (forward)
- 30.39
- EPS (trailing)
- $6.11
- Dividend yield
- —
- Beta
- 0.89
- Avg. volume
- 1.67M
How Veeva Systems Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Mar 20, 2026 · via SEC EDGAR / Finnhub
Forecasts
27 analyst ratings
Veeva Systems Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- VEEVVeeva Systems Inc. Class A Common Stock$310.36▼ 0.85%Market cap $35.54BP/E 47.36$148.05$309.32
- STRCStrategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock$97.72▼ 1.82%Market cap $36.14BP/E —$81.81$312.71
- STRFStrategy Inc 10.00% Series A Perpetual Strife Preferred Stock$103.6▼ 0.20%Market cap $36.81BP/E —$81.81$312.71
- MSTRStrategy Inc Common Stock Class A$136.83▼ 9.56%Market cap $37.21BP/E —$81.81$312.71
- MDBMongoDB Inc. Class A Common Stock$337.57▼ 7.89%Market cap $29.76BP/E 493.29$215.68$473.1
- TWLOTwilio Inc. Class A Common Stock$244.37▼ 10.62%Market cap $29.32BP/E 36.29$104.5$308.4
- TEAMAtlassian Corporation Class A Common Stock$207.82▼ 4.28%Market cap $27.96BP/E —$56.01$214.77
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| VEEV Veeva Systems Inc. Class A Common Stock | $35.54B | 47.36 | $310.36 | ▼ 0.85% | $148.05$309.32 |
| STRC Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock | $36.14B | — | $97.72 | ▼ 1.82% | $81.81$312.71 |
| STRF Strategy Inc 10.00% Series A Perpetual Strife Preferred Stock | $36.81B | — | $103.6 | ▼ 0.20% | $81.81$312.71 |
| MSTR Strategy Inc Common Stock Class A | $37.21B | — | $136.83 | ▼ 9.56% | $81.81$312.71 |
| MDB MongoDB Inc. Class A Common Stock | $29.76B | 493.29 | $337.57 | ▼ 7.89% | $215.68$473.1 |
| TWLO Twilio Inc. Class A Common Stock | $29.32B | 36.29 | $244.37 | ▼ 10.62% | $104.5$308.4 |
| TEAM Atlassian Corporation Class A Common Stock | $27.96B | — | $207.82 | ▼ 4.28% | $56.01$214.77 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- $1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Todaybenzinga · 10/13/2026
- Veeva Systems’ (VEEV) Comeback Gets Jim Cramer TalkingYahoo · 10/10/2026
- Reasons to Hold Veeva Systems Stock in Your Portfolio for NowYahoo · 10/9/2026
- Wall Street Left Software for Dead: 4 Stocks Institutions Are Buying BackYahoo · 10/9/2026
- Veeva (VEEV) Stock May Be 11% Below Fair Value After Biotech Adoption NewsYahoo · 10/9/2026
- 2 Growth Stocks to Buy in OctoberYahoo · 10/8/2026
- Software Leader Veeva Systems Positioned To Hit Buy Points After Nearly DoublingYahoo · 10/8/2026
- Veeva Summit to Showcase AI Innovations and the Leaders Transforming R&D and QualityYahoo · 10/8/2026
- Veeva Systems (NYSE:VEEV): Strong Growth Meets a High-Quality Technical SetupChartMill · 10/8/2026
Insider Activity
Insider Actions →- Rizzo Daniel J · October 2, 2026 · Sale321 @ $276.21
- Rizzo Daniel J · October 2, 2026 · Sale4.5K @ $276.53
- Jonathan Faddis · October 2, 2026 · Gift803
- Eleni Nitsa Zuppas · October 1, 2026 · Option Exercise2.2K
- Eleni Nitsa Zuppas · October 1, 2026 · Tax Withholding1.1K @ $281.93
- Van Wagener Brian · October 1, 2026 · Option Exercise1.6K
- Van Wagener Brian · October 1, 2026 · Tax Withholding705 @ $281.93
- Thomas D. Schwenger · October 1, 2026 · Option Exercise2.9K
- Thomas D. Schwenger · October 1, 2026 · Tax Withholding1.3K @ $281.93
- Rizzo Daniel J · October 1, 2026 · Option Exercise1.7K
- Rizzo Daniel J · October 1, 2026 · Tax Withholding854 @ $281.93
- Vipin Kondath · October 1, 2026 · Option Exercise168
- Vipin Kondath · October 1, 2026 · Tax Withholding61 @ $281.93
- Jonathan Faddis · October 1, 2026 · Option Exercise1.6K
- Jonathan Faddis · October 1, 2026 · Tax Withholding833 @ $281.93
Institutional Ownership
March 31, 2026
- Total shares held
- 127.19M
- Total value held
- $20.96B
- Institutional holders
- 1009
- Unknown11.56M
- Unknown6.67M
- Unknown6.27M
- Unknown4.92M
- Unknown4.14M
- Unknown3.61M
- Unknown3.41M
- Unknown3.31M
- Unknown2.61M
- Unknown2.60M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Veeva Gains Investor Attention Amid R&D Growth and AI Focus
Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.
Veeva Gains Investor Attention Amid R&D Growth and AI Focus. Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.